President Trump’s executive order changing the classification of marijuana could lower taxes for some businesses and prompt new research.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
President Donald Trump signed an executive order last week pressuring states to drop efforts to regulate AI on their own.
The Chinese government has discouraged companies and government-funded data centers from buying Nvidia’s chips.
Wealth managers have reservations on whether the next chair will remain independent of political influence.
Ahead of the Federal Open Market Committee’s meeting Wednesday, the CME Group’s FedWatch tool has the odds of a quarter-point cut at 87%.
The company’s chief investment strategist warned policy moves can take months or years to ripple through the broader economy.
China stopped buying US soybeans altogether in May, two months after suspending the import licenses of US-based CHS Inc.
AstraZeneca is the biggest drugmaker in Britain and its £193 billion ($253 billion) market capitalization tops the London Stock Exchange.
Shell and BP shares rose roughly 3% on Thursday, while US majors Exxon Mobil and Chevron were more muted, up 1.1% and 0.6% respectively.
What’s one little government closure on top of tariffs, geopolitical conflicts, and AI disruptions.
When all is said and done (or if all is said and done), Oracle, Silver Lake and MGX are expected to control about 50% of the company.
According to US Customs, untaxed “de minimis” shipments accounted for 92% of all cargo entering the US, or 4 million packages a day.
Mixing politics and investing is like mixing emotions and math: It rarely adds up.
After several funds from the startup Yieldstreet resulted in total losses, experts questioned the role of private investments in client portfolios.
The filing marks President Trump’s latest move to bring his spot bitcoin strategy to the ETF market. Will advisors bite?
Some praised the move while others said alts in employee-sponsored retirement plans conflict with fiduciary standards and can harm clients.